The popliteal artery is highly exposed to biomechanical stress, which is the primary factor associated with stent failure. However, information on the optimal endovascular treatment for the popliteal artery is lacking.
OBJECTIVE:
To report the efficacy of the GORE® TIGRIS® Vascular Stent for the endovascular treatment of popliteal artery lesions.
METHODS:
Retrospective analysis of all patients with symptoms of peripheral artery occlusive disease (PAD) and popliteal artery lesions who underwent implantation of a GORE® TIGRIS® Vascular Stent between August 2012 and August 2014 at a tertiary vascular centre.
RESULTS:
Between August 2012 and August 2014, 48 patients (32 men, aged 75±8 years) were treated with a GORE® TIGRIS® Vascular Stent. The technical success rate was 100%. At 12 months, the primary and secondary patency rates were 74% and 85%, respectively. During follow-up, no stent fracture was observed. No major amputations were performed.
CONCLUSIONS:
Our study showed that isolated popliteal artery lesions in patients with symptomatic PAD could easily be treated with the GORE® TIGRIS® Vascular Stent, as good short-term results were achieved at 12 months. Therefore, the discontinuation of this product removed a useful tool with a simple release mechanism from the endovascular armamentarium of vascular specialists.
AboyansV, RiccoJB, BartelinkMEL, BjörckM, BrodmannM, CohnertT, et al. Editor’s choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS), Eur J VascEndovasc Surg.2018;55:305–68. doi: 10.1016/j.ejvs.2017.07.018.
2.
KoeckerlingD, RaguindinPF, KastratiL, BernhardS, BarkerJ, Quiroga Centeno AC, et al. Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: A meta-analysis, Eur Heart J.2023;44:935–50. doi: 10.1093/eurheartj/ehac722.
HoffmannU, VetterJ, RainoniL, LeuAJ, BollingerAPopliteal artery compression and force of active plantar flexion in young healthy volunteers, J Vasc Surg.1997;26:281–7. doi: 10.1016/s0741-5214(97)70190-3.
5.
GiannopoulosS, StrobelA, RudofkerE, KovachC, SchneiderPA, ArmstrongEJAssociation of postangioplasty femoropopliteal dissections with outcomes after drug-coated balloon angioplasty in the femoropopliteal arteries, J Endovasc Ther.2021;28:593–603. doi: 10.1177/15266028211016441.
6.
GrayWA, CardenasJA, BrodmannM, WernerM, BernardoNI, GeorgeJC, et al. Treating post-angioplasty dissection in the femoropopliteal arteries using the tack endovascular system: 12-month results from the TOBA II study, JACC Cardiovasc Interv2019;12:2375–84. doi: 10.1016/j.jcin.2019.08.005.
7.
ParthipunA, DiamantopoulosA, KitrouP, PadayacheeS, KarunanithyN, AhmedI, et al. Use of a new hybrid heparin-bonded nitinol ring stent in the popliteal artery: Procedural and mid-term clinical and anatomical outcomes, Cardiovasc Intervent Radiol.2015;38:846–54. doi: 10.1007/s00270-015-1113-4.
8.
PiorkowskiM, FreitasB, SchmidtA, BräunlichS, UlrichM, SchusterJ, et al. The use of the GORE® TIGRIS®Vascular Stent with dual component design in the superficial femoraland popliteal arteries at 6 months, J Cardiovasc Surg (Torino)2013;54:447–53.
9.
RutherfordRB, BakerJD, ErnstC, JohnstonKW, PorterJM, AhnS, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version, J Vasc Surg.1997;26:517–38. doi: 10.1016/s0741-5214(97)70045-4.
10.
NorgrenL, HiattWR, DormandyJA, NehlerMR, HarrisKA, FowkesFGTASC II Working GrouInter-society consensus for the management of peripheral arterial disease (TASC II), J Vasc Surg.2007;45(Suppl S):S5–67. doi: 10.1016/j.jvs.2006.12.037.
11.
MaleckisK, AnttilaE, AylwardP, PoulsonW, DesyatovaA, MacTaggartJ, et al. Nitinol stents in the femoropopliteal artery: A mechanical perspective on material, design, and performance, Ann Biomed Eng.2018;46:684–704. doi: 10.1007/s10439-018-1990-1.
12.
SibéM, KaladjiA, BoiratC, CardonA, ChaufourX, BossavyJP, et al. French multicenter experience with theGORE TIGRIS Vascular Stent in superficial femoral and popliteal arteries, J Vasc Surg2017;65:1329–35. doi: 10.1016/j.jvs.2016.11.056.
13.
TroisiN, SaratzisA, KatsogridakisE, StavroulakisK, BerchiolliR, ZayedH, et al. EMO-POP Registry Collaborative GrouDifferent endovascular modalities of treatment for isolated atherosclerotic popliteal artery lesions (EMO-POP) registry, J Vasc Surg77 (2023):231–40.e4. doi: 10.1016/j.jvs.2022.07.170.
14.
SalamagaS, Stepak H, KrasińskiZSupera stent implantation for the treatment of isolated poplitealartery disease systematic review and evaluation of current endovascular strategies, Pol Przegl Chir.2022;95:1–7. doi: 10.5604/01.3001.0015.9578.
15.
LichtenbergM, ZellerT, GainesP, PiorkowskiMMIMICS-3D investigators. BioMimics 3D vascular stent system for femoropopliteal interventions, Vasa.2022;51(1):5–12. doi: 10.1024/0301-1526/a000980.
16.
GouëfficY, TorselloG, ZellerT, EspositoG, VermassenF, HauseggerKA, et al. EMINENT investigators, Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: Primary results of the EMINENT randomized trial. Circulation2022;146:1564–76. doi: 10.1161/CIRCULATIONAHA.122.059606.
17.
RuffinoMA, FrondaM, BergamascoL, NatrellaM, FanelliG, BellostaR, et al. Prognostic risk factors for loss of patency after femoropopliteal bailout stenting with dual-component stent: Results from the TIGRIS Italian Multicenter Registry, Radiol Med2021;126:1129–37. doi: 10.1007/s11547-021-01373-5.
18.
HajibandehS, AntoniouSA, TorellaF, AntoniouGACovered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: A systematic review and meta-analysis, J Endovasc Ther.2016;23:442–52. doi: 10.1177/1526602816643834.
19.
DeCarloC, BoitanoLT, LatzCA, PngCYM, LeeS, DuaA, et al. Patients with failed femoropopliteal covered stents are more likely to present with acute limb ischemia than those with failed femoropopliteal bare metal stents, J Vasc Surg74 (2021):161–9.e1. doi: 10.1016/j.jvs.2021.01.029.
20.
KokkalisE, AristokleousN, HoustonJGHaemodynamics and flow modification stents for peripheral arterialdisease: A review, Ann Biomed Eng.2016;44(2):466–76. doi: 10.1007/s10439-015-1483-4.
21.
MaleckisK, DeeganP, PoulsonW, SieversC, DesyatovaA, MacTaggartJ, et al. Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations, J MechBehav Biomed Mater.2017;75:160–8. doi: 10.1016/j.jmbbm.2017.07.017.
